Clinical Trial Update: A "Window Trial" on Curcumin for Invasive Breast Cancer Primary Tumors [Phase 1]

View source ↗

Summary

A Phase 1 window trial assessing curcumin for invasive breast cancer primary tumors has completed, per sponsor Medical University of South Carolina.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Curcumin (curcumin)

Snippet

Sponsor: Medical University of South Carolina | Conditions: Breast Cancer | Phase 1 | Status: COMPLETED